Smith Mark Douglas (CIK 1756253) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-26). Recent activity: Buy PHR (19,290 shares), Sell JAZZ (1,157 shares), Buy JAZZ (3,507 shares), Sell JAZZ (1,805 shares), Buy PHR (7,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Phreesia, Inc. (PHR) | Director | Buy | 19,290 | $184,991 |
| 2026-06-17 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,157 | $266,746 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Buy | 3,507 | $0 |
| 2025-08-11 | Jazz Pharmaceuticals plc (JAZZ) | Director | Sell | 1,805 | $200,806 |
| 2025-07-03 | Phreesia, Inc. (PHR) | Director | Buy | 7,000 | $32,970 |
| 2025-07-03 | Phreesia, Inc. (PHR) | Director | Sell | 7,000 | $203,000 |
| 2025-06-27 | Phreesia, Inc. (PHR) | Director | Buy | 6,700 | $184,987 |
Source: SEC Form 4 filings · as of 2026-06-26